반응식
N1[CH:6]=[CH:5][C:4]2[C:7]([O:9][C:10](=[O:11])[C:3]=2[CH:2]=1)=O.[NH2:12][CH:13]1[CH2:19][CH2:18][C:17](=[O:20])[NH:16][C:14]1=[O:15].[CH2:21](N(CC)CC)C>>[C:10]([C:13]1([NH2:12])[CH2:19][CH2:18][C:17](=[O:20])[NH:16][C:14]1=[O:15])([O:9][CH2:7][C:4]1[CH:5]=[CH:6][CH:21]=[CH:2][CH:3]=1)=[O:11]참가 물질
4
실험 절차
With reference to Scheme 4 below, azathalidomide was prepared from aminoglutarimide and commercial pyridine-3,4-dicarboxylic anhydride. Cbz-aminoglutarimide was deprotected by hydrogenolysis with catalyst palladium hydroxide on carbon (10%) to form aminoglutarimide. Pyridine-3,4-dicarboxyic anhydride was refluxed with aminoglutarimide in the presence of triethylamine to yield azathalidomide 11 in the total yield of 17% from Cbz-aminoglutarimide.
출처 및 근거
- ORD 기록
- ord-ce699545f7fa4c82baa51d40f8c107be
- 출처 데이터셋
- uspto-grants-2014_10
- 특허 번호
- US08853253B2
연결된 노트
불러오는 중…